Global Age Related Macular Degeneration Biologic Drug Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Age Related Macular Degeneration is a common eye disease that is the leading cause of vision loss in people aged 50 years and older. It causes damage to the macula, a small spot near the center of the retina and a part of the eye needed for sharp central vision, allowing us to see the object in front of it. Age Related Macular Degeneration Drug refers to the drugs used to treat Age Related Macular Degeneration.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Age Related Macular Degeneration Biologic Drug market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Age Related Macular Degeneration Biologic Drug market are covered in Chapter 9:
Genentech
Bayer
Regeneron
Ophthotech Corporation
Allergan
Eli Lilly
Merck
Valeant
Acucela
Novartis
Alimera Sciences
In Chapter 5 and Chapter 7.3, based on types, the Age Related Macular Degeneration Biologic Drug market from 2017 to 2027 is primarily split into:
Ranibizumab
Bevacizumab
Aflibercept
In Chapter 6 and Chapter 7.4, based on applications, the Age Related Macular Degeneration Biologic Drug market from 2017 to 2027 covers:
Outpatient Surgery Center
Eye Clinic
Hospital
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Age Related Macular Degeneration Biologic Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Age Related Macular Degeneration Biologic Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Age Related Macular Degeneration Biologic Drug Market
1.2 Age Related Macular Degeneration Biologic Drug Market Segment by Type
1.2.1 Global Age Related Macular Degeneration Biologic Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Age Related Macular Degeneration Biologic Drug Market Segment by Application
1.3.1 Age Related Macular Degeneration Biologic Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Age Related Macular Degeneration Biologic Drug Market, Region Wise (2017-2027)
1.4.1 Global Age Related Macular Degeneration Biologic Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.4 China Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.6 India Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Age Related Macular Degeneration Biologic Drug (2017-2027)
1.5.1 Global Age Related Macular Degeneration Biologic Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Age Related Macular Degeneration Biologic Drug Market
2 INDUSTRY OUTLOOK
2.1 Age Related Macular Degeneration Biologic Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Age Related Macular Degeneration Biologic Drug Market Drivers Analysis
2.4 Age Related Macular Degeneration Biologic Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Age Related Macular Degeneration Biologic Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Age Related Macular Degeneration Biologic Drug Industry Development
3 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Age Related Macular Degeneration Biologic Drug Average Price by Player (2017-2022)
3.4 Global Age Related Macular Degeneration Biologic Drug Gross Margin by Player (2017-2022)
3.5 Age Related Macular Degeneration Biologic Drug Market Competitive Situation and Trends
3.5.1 Age Related Macular Degeneration Biologic Drug Market Concentration Rate
3.5.2 Age Related Macular Degeneration Biologic Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.5 Europe Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.6 China Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.7 Japan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.8 India Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.9 Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.10 Latin America Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.11 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Under COVID-19
5 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Age Related Macular Degeneration Biologic Drug Price by Type (2017-2022)
5.4 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Ranibizumab (2017-2022)
5.4.2 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Bevacizumab (2017-2022)
5.4.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Aflibercept (2017-2022)
6 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Age Related Macular Degeneration Biologic Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2017-2022)
6.3.2 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2017-2022)
6.3.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2017-2022)
7 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET FORECAST (2022-2027)
7.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Age Related Macular Degeneration Biologic Drug Price and Trend Forecast (2022-2027)
7.2 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Ranibizumab (2022-2027)
7.3.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Bevacizumab (2022-2027)
7.3.3 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Aflibercept (2022-2027)
7.4 Global Age Related Macular Degeneration Biologic Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Outpatient Surgery Center(2022-2027)
7.4.2 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Eye Clinic(2022-2027)
7.4.3 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Hospital(2022-2027)
7.5 Age Related Macular Degeneration Biologic Drug Market Forecast Under COVID-19
8 AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Age Related Macular Degeneration Biologic Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Age Related Macular Degeneration Biologic Drug Analysis
8.6 Major Downstream Buyers of Age Related Macular Degeneration Biologic Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Age Related Macular Degeneration Biologic Drug Industry
9 PLAYERS PROFILES
9.1 Genentech
9.1.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.1.3 Genentech Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer
9.2.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.2.3 Bayer Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Regeneron
9.3.1 Regeneron Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.3.3 Regeneron Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Ophthotech Corporation
9.4.1 Ophthotech Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.4.3 Ophthotech Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Allergan
9.5.1 Allergan Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.5.3 Allergan Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Eli Lilly
9.6.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.6.3 Eli Lilly Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck
9.7.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.7.3 Merck Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Valeant
9.8.1 Valeant Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.8.3 Valeant Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Acucela
9.9.1 Acucela Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.9.3 Acucela Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Novartis
9.10.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.10.3 Novartis Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Alimera Sciences
9.11.1 Alimera Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.11.3 Alimera Sciences Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Age Related Macular Degeneration Biologic Drug Market
1.2 Age Related Macular Degeneration Biologic Drug Market Segment by Type
1.2.1 Global Age Related Macular Degeneration Biologic Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Age Related Macular Degeneration Biologic Drug Market Segment by Application
1.3.1 Age Related Macular Degeneration Biologic Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Age Related Macular Degeneration Biologic Drug Market, Region Wise (2017-2027)
1.4.1 Global Age Related Macular Degeneration Biologic Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.4 China Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.6 India Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Age Related Macular Degeneration Biologic Drug (2017-2027)
1.5.1 Global Age Related Macular Degeneration Biologic Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Age Related Macular Degeneration Biologic Drug Market
2 INDUSTRY OUTLOOK
2.1 Age Related Macular Degeneration Biologic Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Age Related Macular Degeneration Biologic Drug Market Drivers Analysis
2.4 Age Related Macular Degeneration Biologic Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Age Related Macular Degeneration Biologic Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Age Related Macular Degeneration Biologic Drug Industry Development
3 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Age Related Macular Degeneration Biologic Drug Average Price by Player (2017-2022)
3.4 Global Age Related Macular Degeneration Biologic Drug Gross Margin by Player (2017-2022)
3.5 Age Related Macular Degeneration Biologic Drug Market Competitive Situation and Trends
3.5.1 Age Related Macular Degeneration Biologic Drug Market Concentration Rate
3.5.2 Age Related Macular Degeneration Biologic Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.5 Europe Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.6 China Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.7 Japan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.8 India Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.9 Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.10 Latin America Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Age Related Macular Degeneration Biologic Drug Market Under COVID-19
4.11 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Under COVID-19
5 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Age Related Macular Degeneration Biologic Drug Price by Type (2017-2022)
5.4 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Ranibizumab (2017-2022)
5.4.2 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Bevacizumab (2017-2022)
5.4.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Growth Rate of Aflibercept (2017-2022)
6 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Age Related Macular Degeneration Biologic Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2017-2022)
6.3.2 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2017-2022)
6.3.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2017-2022)
7 GLOBAL AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET FORECAST (2022-2027)
7.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Age Related Macular Degeneration Biologic Drug Price and Trend Forecast (2022-2027)
7.2 Global Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Ranibizumab (2022-2027)
7.3.2 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Bevacizumab (2022-2027)
7.3.3 Global Age Related Macular Degeneration Biologic Drug Revenue and Growth Rate of Aflibercept (2022-2027)
7.4 Global Age Related Macular Degeneration Biologic Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Outpatient Surgery Center(2022-2027)
7.4.2 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Eye Clinic(2022-2027)
7.4.3 Global Age Related Macular Degeneration Biologic Drug Consumption Value and Growth Rate of Hospital(2022-2027)
7.5 Age Related Macular Degeneration Biologic Drug Market Forecast Under COVID-19
8 AGE RELATED MACULAR DEGENERATION BIOLOGIC DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Age Related Macular Degeneration Biologic Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Age Related Macular Degeneration Biologic Drug Analysis
8.6 Major Downstream Buyers of Age Related Macular Degeneration Biologic Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Age Related Macular Degeneration Biologic Drug Industry
9 PLAYERS PROFILES
9.1 Genentech
9.1.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.1.3 Genentech Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer
9.2.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.2.3 Bayer Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Regeneron
9.3.1 Regeneron Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.3.3 Regeneron Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Ophthotech Corporation
9.4.1 Ophthotech Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.4.3 Ophthotech Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Allergan
9.5.1 Allergan Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.5.3 Allergan Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Eli Lilly
9.6.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.6.3 Eli Lilly Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck
9.7.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.7.3 Merck Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Valeant
9.8.1 Valeant Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.8.3 Valeant Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Acucela
9.9.1 Acucela Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.9.3 Acucela Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Novartis
9.10.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.10.3 Novartis Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Alimera Sciences
9.11.1 Alimera Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Age Related Macular Degeneration Biologic Drug Product Profiles, Application and Specification
9.11.3 Alimera Sciences Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Age Related Macular Degeneration Biologic Drug Product Picture
Table Global Age Related Macular Degeneration Biologic Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Age Related Macular Degeneration Biologic Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Age Related Macular Degeneration Biologic Drug Industry Development
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume by Player (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Share by Player (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Share by Player in 2021
Table Age Related Macular Degeneration Biologic Drug Revenue (Million USD) by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Revenue Market Share by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Price by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume, Region Wise (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise in 2021
Table Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise in 2021
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume by Type (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share by Type in 2021
Table Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) by Type (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Type in 2021
Table Age Related Macular Degeneration Biologic Drug Price by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Ranibizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Bevacizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Aflibercept (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Price and Trend Forecast (2022-2027)
Figure USA Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Price Forecast, by Type
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2022-2027)
Table Global Age Related Macular Degeneration Biologic Drug Market Consumption Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share Forecast, by Application
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Outpatient Surgery Center (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Eye Clinic (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Age Related Macular Degeneration Biologic Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Genentech Profile
Table Genentech Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Genentech Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table Regeneron Profile
Table Regeneron Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Regeneron Revenue (Million USD) Market Share 2017-2022
Table Ophthotech Corporation Profile
Table Ophthotech Corporation Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ophthotech Corporation Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Ophthotech Corporation Revenue (Million USD) Market Share 2017-2022
Table Allergan Profile
Table Allergan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allergan Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Allergan Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Valeant Profile
Table Valeant Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Valeant Revenue (Million USD) Market Share 2017-2022
Table Acucela Profile
Table Acucela Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acucela Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Acucela Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Alimera Sciences Profile
Table Alimera Sciences Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alimera Sciences Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Alimera Sciences Revenue (Million USD) Market Share 2017-2022
Figure Age Related Macular Degeneration Biologic Drug Product Picture
Table Global Age Related Macular Degeneration Biologic Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Age Related Macular Degeneration Biologic Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Age Related Macular Degeneration Biologic Drug Industry Development
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume by Player (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Share by Player (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Share by Player in 2021
Table Age Related Macular Degeneration Biologic Drug Revenue (Million USD) by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Revenue Market Share by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Price by Player (2017-2022)
Table Age Related Macular Degeneration Biologic Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume, Region Wise (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share, Region Wise in 2021
Table Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share, Region Wise in 2021
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume by Type (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share by Type in 2021
Table Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) by Type (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Type in 2021
Table Age Related Macular Degeneration Biologic Drug Price by Type (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Ranibizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Bevacizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate of Aflibercept (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2017-2022)
Table Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2017-2022)
Figure Global Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Price and Trend Forecast (2022-2027)
Figure USA Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Age Related Macular Degeneration Biologic Drug Market Sales Volume Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Sales Volume Market Share Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Price Forecast, by Type
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Ranibizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Bevacizumab (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (Million USD) and Growth Rate of Aflibercept (2022-2027)
Table Global Age Related Macular Degeneration Biologic Drug Market Consumption Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Market Revenue (Million USD) Forecast, by Application
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share Forecast, by Application
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Outpatient Surgery Center (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Eye Clinic (2022-2027)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Age Related Macular Degeneration Biologic Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Genentech Profile
Table Genentech Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Genentech Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table Regeneron Profile
Table Regeneron Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Regeneron Revenue (Million USD) Market Share 2017-2022
Table Ophthotech Corporation Profile
Table Ophthotech Corporation Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ophthotech Corporation Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Ophthotech Corporation Revenue (Million USD) Market Share 2017-2022
Table Allergan Profile
Table Allergan Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allergan Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Allergan Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Valeant Profile
Table Valeant Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Valeant Revenue (Million USD) Market Share 2017-2022
Table Acucela Profile
Table Acucela Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acucela Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Acucela Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Alimera Sciences Profile
Table Alimera Sciences Age Related Macular Degeneration Biologic Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alimera Sciences Age Related Macular Degeneration Biologic Drug Sales Volume and Growth Rate
Figure Alimera Sciences Revenue (Million USD) Market Share 2017-2022
